Evaluating Effective Communication and Thorough Explanation in Promoting Participation in Clinical Research by Yue, Yin









Department of Emergency Medicine, Lehigh Valley Health Network 
2
Research Scholar Program Mentor 
 
Abstract 
The historic gender disparity in participation in clinical research has resulted in many difficulties in generalizing 
research study results. The purposes of this pilot were to investigate experience, attitudes and barriers for women's 
participation in clinical research and find the strategies to enhance recruitment as well as supportive resources to 
facilitate their participation. Eligible female patients at LVHN Center for Women's Medicine (CWM) were 
approached and invited to take the survey, which was translated into four different languages. Outcomes indicate 
that women from all backgrounds are open to supportive resources to help them better understand the research study 
and to facilitate their participation. Effective communication with the doctors and researchers can also reduce 
mistrust and overcome this barrier which would potentially prevent women from participating in clinical research.  
Keywords 
Participation in clinical research, women and minority, communication and explanation, language barrier 
Introduction 
Historically, there has always been a significant gender 
disparity in participation in clinical research – a 
majority of clinical trials are found to have inadequate 
inclusion of women. This under-representation is 
attributable, in large part, to a 1977 regulation issued by 
the Food and Drug Administration (FDA), which 
excluded women of childbearing potential from Phase I 
drug trials (Rodger et al., 2003). Sadly, even after the 
FDA explicitly reversed its 1977 policy of exclusion 
and after federal funding organizations started 
emphasizing women's inclusion in studies, women of 
all ages are still under-represented in trials in all phases 
of development. A report published in 2009 found that 
the average enrollment of women in Phase III to IV 
randomized cardiovascular trials from 1997 to 2006 
was only 27% (Kim & Menon, 2009). Reports also 
indicate that rates of participation in clinical trials are 
especially low among the socially disadvantaged and 
racial/ethnic minority groups, deepening the disparities 
even further (Giuliano et al., 2000).  
The inadequate women and minority enrollment in 
clinical trials remains one of the greatest challenges for 
both research and public health reasons as it reduces the 
ability to generalize study results. Therefore, a few 
studies have been done in recent years to investigate the 
factors that potentially influence the successful 
recruitment of both groups into clinical research trials. 
Many of them have identified the overall lack of trust in 
healthcare systems and researchers as one of the most 
significant barriers (Smith, 2007). Further, it is reported 
that this kind of suspicion and mistrust is increased 
when language becomes a barrier (Giarell, 2011). All 
participants, not just minorities, want to feel that they 
are valued and appreciated, which may only be 
achieved when researchers thoroughly explain the trial, 
including its benefits and potential side effects. 
Therefore, at an FDA conference held in 2011, a 
number of speakers from the clinical research field 
stressed the need for transparent communication to 
overcome the history of distrust (Coakley, 2012). At 
this stage, a large scale, prospective investigation is 
needed in order to produce generalizable data and draw 
authoritative conclusions.  
This diversity study is a part of the first multi-center 
study, which investigates experience, attitudes and 
barriers for women's participation in clinical research. 
Through this study, we hope to find the strategies to 
enhance recruitment as well as supportive resources to 
boost women and minorities' comfort level with clinical 
research (Kurt, 2015). We hypothesize that a thorough 
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and factual explanation of the research study can be a 
strong motivation for women who consider "distrust in 
doctors" as a barrier. In addition, women from all 
backgrounds are open to supportive resources to 
facilitate their participation, especially those that ensure 
effective communication with the doctors/researchers. 
It is also hypothesized that better communication and 
explanation is especially important to non-English 
speaking women.  
Methods 
This descriptive pilot explores perceived barriers and 
motivators to women's participation in clinical research. 
We aim to find preferred resources to overcome barriers 
and facilitate their participation. We analyzed data 
collected through surveys to answer the following 
research questions:  
1) Is there a correlation between "how well the research 
study is explained to me" as a motivating factor and 
women's distrust in doctors as a barrier to their 
participation?  
2) Are women and minorities open to supportive 
resources to boost their determination and comfort level 
with clinical research? 
3) Do non-English speaking women consider more 
effective communication and thorough explanation 
more important than English speaking women?  
Participants 
The study targeted female patients who were at least 18 
years of age. Patient must be both mentally and 
physically competent to take the survey on her own. A 
woman was not eligible if she was not there to be seen 
by a medical staff on the day the survey was conducted. 
Approval for human subject research was obtained 
from the Institutional Review Board (IRB) at Lehigh 
Valley Health Network (LVHN).  
Recruitment 
Female patients were recruited, during regular clinic 
hours, in the waiting area of LVHN Center for 
Women's Medicine (CWM) in Allentown, 
Pennsylvania. This center primarily serves urban areas, 
providing comprehensive health care for women, and 
approximately 40% of patients are minorities. 
Recruiters were LVHN Research Scholars, who were 
trained specifically for this clinical research recruitment. 
All of them were bilingual in English and in either 
Spanish or Chinese.  
Recruiters approached female patients who they 
determined met eligible criteria and explained the study, 
including its purpose and required action from the 
individual to participate. Patients were informed of their 
right not to participate and right to stop at any time. 
Those who agreed to participate were presented the 
language-appropriate survey for completion.  
Data Collection and Entry  
Data were collected through surveys. The survey was 
piloted among 15 non-research and non-clinical staff at 
LVHN for their review prior to its distribution in clinics. 
To target a diverse population, this survey was 
professionally translated into Spanish, Traditional 
Chinese and Simplified Chinese. All were approved by 
the IRB at LVHN.  
The survey asked a combination of multiple-choice 
questions and rating questions regarding the 
individual's knowledge, experiences, perceptions and 
attitudes regarding clinical research. It sought out basic 
demographic information, but no identifiers or 
Protected Health Information (PHI) was collected.  
A patient participation log was maintained to indicate 
how many patients were approached for the survey and 
how many agreed to participate. All responses were 
entered into a password-protected database by the 
Research Coordinator.  
Data Analysis  
Data Analysis was completed by the author using 
Microsoft Excel. Descriptive statistics included means 
and standard deviations for continuous variables and 
tables for categorical variables (Kurt, 2015). Chi-square 
test was also used to assess whether the differences 
were statistically significant.  
Results 
Sample Characteristics 
Over a period of 5 weeks, we got our preliminary data 
from a total of 400 female patients who agreed to 
participate and completed the survey. Among them, 21% 
identified themselves as White or Caucasian and 74.3% 
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as minorities which included Black or African 
American, Asian, Hispanic/Latin, and other. Despite 
their race, 45.5% of participants indicated that they only 
spoke English at home, and the remainder either only 
spoke one foreign language (23.5%) or spoke both 
English and another language (27.0%). The majority 
(74.0%, N=296) reported speaking and understanding 
English very well, but there was still a noticeable 
number of participants who cannot speak English at all 
(N=15). For additional characteristics, see Table 1.  
Overall Ratings on Attitudinal Statements 
Attitudinal statements regarding clinical research were 
evaluated in a 0 – 4 Likert scale, where 0 meant "no 
motivation" and 4 represented "most motivation". The 
group of 400 female participants gave an overall rate of 
2.95 to "how well the research study was explained to 
me" as a motivating factor. The majority of participants 
indicated that their distrust in doctors created "some 
barrier" preventing them from participation in clinical 
research (Mean=2.09). On average, women rated the 
proposed supportive resources at 2.62, indicating that 
those resources could bring "some" to "significant help". 
The highest average rating of 2.89 was given to "having 
all material provided in my language" (See Table 2).  
 
Effectiveness of Explanation and Language Tools 
Stratified by English proficiency and the language 
spoken at home, the correlation between the distrust in 
doctors and quality of explanation was illustrated in 
Figure 1 and 2. 
Table 1. Characteristics of the Study Sample 
Characteristics  (N=400) Range Mean, SD 
Age (years) 18 – 88 29.9, 10.4 
 N  Total %* 
Past research participation   
     Never participated 369 92.3 
     Participated once 24 6.0 
     Participated more than 
once 
4 1.0 
Race   
     White or Caucasian 84 21.0 
     Black or African 
American  
35 8.75 
     Asian 8 2.0 
     Hispanic/Latina/Mexican/ 
        Puerto 
Rican/Dominican/ 
        Colombian/Spanish 
214 53.5 
     Other 40 10.0 
Spoken language   
     English only 182 45.5 
     Other language only 94 23.5 
     English + another 
language  
108 27.0 
English proficiency   
     Very well 296 74.0 
     Pretty good 23 5.8 
     Understand English, but  
         hard to speak 
50 12.5 
     Cannot speak English  15 3.8 
Education   
     < High school 62 15.5 
     High school 
graduate/GED 
143 35.8 
     Some college/2 year 
degree 
135 33.8 
     4 year college graduate 24 6.0 
     > 4 year college degree  18 4.5 
Annual income   
     < $30,000 221 55.3 
     ≥ $30,000 137 34.3 
*Percentages are based on valid cases. Total percent 
may not always equal 100% because of incompletion.    
Table 2. Average Ratings on Attitudinal Statements  
Variable  Mean, Md, SD 
Potential barriers  
   My distrust in doctors 2.09, 2.00, 1.46 
Motivating factors    
   How well the research study  
        is explained to me 
2.95, 3.00, 1.28 
   The doctor conducting the research  
        speaks the same language  
1.83, 2.00, 1.55 
Helpful Resources    
   Written explanation provided 2.72, 3.00, 1.28 
   DVDs or electronic material        
        explaining the study 
2.60, 3.00, 1.34 
   Having opportunity to speak to       
        patient who has participated 
2.69, 3.00, 1.32 
   Having access to a support group of  
        patients who have participated  
2.46, 3.00, 1.33 
   Having all material provided in  
        my language  
2.89, 3.00, 1.33 
   Having access to a medical  
        interpreter throughout the study 




Figure 3-6 illustrates patients' attitudes towards the 
effectiveness of thorough explanation and language 
tools in promoting participation among women with 

















Figure 1. Ratings of Distrust in Doctors and 















Figure 2. Ratings of Distrust in Doctors and 
Quality of Explanation by English Proficiency 
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Figure 3. English - Very Well 
















Figure 4. English - Pretty Good 














Figure 5. English - Understand, Hard to 
Speak 















Figure 6. English - Cannot Speak 
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Discussion 
Ranging from 18 to 88 years of age, coming from all 
ethnicity background including 21% White or 
Caucasian and 74.3% self-identified minorities, these 
400 female patients well represented a diverse 
population.   
Similar to the previous findings (Smith, 2007), "distrust 
in doctors" remained to be one of the common barriers 
that potentially would prevent women from enrolling in 
clinical research (p=0.018). Among the 400 
participants, "how well the research study was 
explained to me" was very highly rated as an important 
motivating factor (p=0.0017). When we examined this 
motivating factor with the distrust in doctors as a 
potential barrier, we found a close relationship – a 
positive correlation – between the two elements. The 
more the patients considered distrust as a barrier, the 
more likely that they would like to receive better 
explanation of the research study. The progression was 
especially clear among women who were less fluent in 
English (Figure 1,2). Therefore, it was reasonable for us 
to think of language barrier as a source of mistrust, and 
trust could be built through better communication, such 
as a transparent and comprehensive explanation of the 
research study.  
Overall, the majority of women considered supportive 
resources to be somewhat helpful or even significantly 
helpful (Table 2). More women, regardless of their 
English proficiency and language background, rated 
same language explanation and communication as 
"Most Help" (Figure 3-6). Adrian Paskey, a 2014 
LVHN Research Scholar, investigated the rating of 
helpfulness of explanation as well as the rating of 
support tools stratified by education and income 
(Paskey, 2014). Both this study result and her result 
confirmed that women from all backgrounds are open 
to supportive resources to facilitate their participation, 
especially those that ensure effective communication 
with the doctors/researchers. However, because of the 
insufficient number of participants who could not speak 
English (only 5.8%), the p-value of their ratings of the 
better explanation and supportive resource were 0.0823 
and 0.0310 correspondingly. With these p-values, we 
were not confident that the data was statistically 
significant; therefore, whether non-English speaking 
women consider effective communication and 
explanation more important than English speaking 
women, remained unanswered.  
Although the surveys were translated into several 
languages, the recruiter of this study still initiated the 
process in English and, depending on the response of 
the individual, transitioned to speaking in the same 
language as the individual. This process might have 
already created tension for non-English speaking 
women and forestalled their further participation. 
Because of the particular demographic of the area, there 
was a dearth of participation from non-English 
speakers. Therefore, more diverse population in 
different settings would bring more desirable results for 
this study.  
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